Back to today’s briefing

Story perspectives

Healthcare Innovation Faces Tension at Psychedelic Science Conference

6/21/2025

38 8

Summary

Story summary

At the Psychedelic Science Conference in Denver, Meghana Keshavan captures the tension between counterculture and corporate science. The spotlight shines on Gilead's groundbreaking HIV prevention approval, a U.K. agency's refusal of costly Alzheimer’s drugs, and the FDA's concerning silence regarding AI-driven medical devices, raising questions about the future of healthcare innovation.

1 of 1

Story summary

At the Psychedelic Science Conference in Denver, Meghana Keshavan captures the tension between counterculture and corporate science. The spotlight shines on Gilead's groundbreaking HIV prevention approval, a U.K. agency's refusal of costly Alzheimer’s drugs, and the FDA's concerning silence regarding AI-driven medical devices, raising questions about the future of healthcare innovation.